Avacta Group PLC - Wetherby, England-based life sciences company developing oncology drugs and diagnostics - Appoints Christina Coughlin as head of research and development. Coughlin, who will take.
The data confirm the pre|CISIONTM platform s ability to transform the safety profile of doxorubicin through tumour targeting Cohort 7, the final cohort in the three-weekly dose.
Dalriada School's Lydia recognised at Moving Image Arts Showcase northernirelandworld.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from northernirelandworld.com Daily Mail and Mail on Sunday newspapers.
Avacta to present promising new data from Affimer® and pre|CISIONTM platform assets at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics tmcnet.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from tmcnet.com Daily Mail and Mail on Sunday newspapers.